Terazosin
Terazosin Terazosin is a selective α1‑adrenergic receptor blocker used primarily for treating hypertension and benign prostatic hyperplasia (BPH). It relaxes vascular smooth muscle and prostatic urethral smooth muscle, reducing peripheral…
Tepezza
Tepezza Tepezza (teprotumumab-trbw) is a fully human monoclonal antibody targeting the insulin‑like growth factor‑1 receptor (IGF‑1R). It was approved by the FDA in 2020 for the treatment of thyroid‑associated orbitopathy…
Temovate
Temovate Temovate is a commercial ophthalmic formulation of levofloxacin 0.5 %. It is indicated for the treatment of bacterial conjunctivitis, corneal ulcers, and postoperative prophylaxis following ocular surgery. --- Mechanism of…
Temazepam
Temazepam Mechanism of Action Temazepam is a short‑acting benzodiazepine that binds to the γ‑aminobutyric acid‑A (GABA‑A) receptor complex as a positive allosteric modulator. By enhancing GABA‑mediated chloride influx, it increases…
telotristat ethyl
Telotristat Ethyl Telotristat ethyl is a once‑daily oral prodrug that selectively inhibits tryptophan‑hydroxylase‑1 (TPH‑1), the rate‑limiting enzyme in serotonin synthesis. It is approved for the adjunctive treatment of refractory carcinoid‑syndrome…
Telmisartan
Telmisartan Mechanism of Action Telmisartan is a selective blocker of the angiotensin‑II type 1 (AT1) receptor. Competitive antagonist: It binds the AT1 receptor with high affinity, preventing angiotensin‑II from activating the…
Tegretol
Tegretol Brand name for Carbamazepine --- Mechanism of Action Voltage‑gated sodium channel blockade: Suppresses the high‑frequency firing of neurons by prolonging the inactivated state of Na⁺ channels, thereby stabilizing hyper‑excitable…
Tecvayli
Tecvayli Tecvayli (tecovirimat) is an antiviral agent indicated for the treatment of confirmed or suspected monkeypox virus infection in adults and children ≥12 kg, and for smallpox prophylaxis in selected high‑risk…
Tecfidera
Tecfidera Tecfidera (generic name dimethyl fumarate) is an oral disease‑modifying therapy approved for relapsing‑remitting multiple sclerosis (RRMS). It offers a convenient, once‑or‑twice‑daily regimen with a robust evidence base for reducing…
Tecentriq
Tecentriq Tecentriq (generic: pembrolizumab) is a humanized monoclonal antibody targeting the immune checkpoint protein Programmed Death‑1 (PD‑1). It is approved for multiple malignancies, often in combination or as monotherapy, and…